These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 28750745)
1. Corrigendum to "A selective delta opioid receptor antagonist based on a stilbene core" [Bioorg. Med. Chem. Lett. 25 (2015) 5532-5535]. Hartung AM; Navarro HA; Wiemer DF; Neighbors JD Bioorg Med Chem Lett; 2016 Mar; 26(6):1645. PubMed ID: 28750745 [No Abstract] [Full Text] [Related]
2. Corrigendum to "Discovery of highly selective κ-opioid receptor agonists: 10α-Hydroxy TRK-820 derivatives" [Bioorg Med Chem Lett 27(16) (2017) 3920-3924]. Suzuki S; Sugawara Y; Tsuji R; Tanimura R; Kaneko C; Yuzawa N; Yagi M; Kawai K Bioorg Med Chem Lett; 2019 Feb; 29(3):515. PubMed ID: 30579796 [No Abstract] [Full Text] [Related]
3. Corrigendum to "Chemical space screening around Phe Willemse T; Eiselt E; Hollanders K; Schepens W; van Vlijmen HWT; Chung NN; Blais V; Holleran B; Longpré JM; Schiller PW; Maes BUW; Sarret P; Gendron L; Ballet S Bioorg Med Chem Lett; 2018 Nov; 28(20):3418. PubMed ID: 30195888 [No Abstract] [Full Text] [Related]
4. Corrigendum to "Identification of substituted benzothiazole sulfones as potent and selective inhibitors of endothelial lipase" [Bioorg. Med. Chem. Lett. 29 (2019) 1918-1921]. Kim SH; Johnson JA; Jiang J; Parkhurst B; Phillips M; Pi Z; Qiao JX; Tora G; Ye Chen A; Liu E; Yin X; Yang R; Zhao L; Taylor DS; Basso M; Behnia K; Onorato J; Chen XQ; Abell LM; Lu H; Locke G; Caporuscio C; Adam LP; Gordon D; Wexler RR; Finlay HJ Bioorg Med Chem Lett; 2019 Sep; 29(17):2525. PubMed ID: 31353296 [No Abstract] [Full Text] [Related]
5. Corrigendum to 'Design and development of a series of borocycles as selective, covalent kallikrein 5 inhibitors' [Bioorg. Med. Chem. Lett. 29 (2019) 126675]. Walker AL; Denis A; Bingham RP; Bouillot A; Edgar EV; Ferrie A; Holmes DS; Laroze A; Liddle J; Fouchet MH; Moquette A; Nassau P; Pearce AC; Polyakova O; Smith KJ; Thomas P; Thorpe JH; Trottet L; Wang Y; Hovnanian A Bioorg Med Chem Lett; 2020 Jan; 30(2):126771. PubMed ID: 31859161 [No Abstract] [Full Text] [Related]
6. Corrigendum to "Design of selective PI3Kδ inhibitors using an iterative scaffold-hopping workflow" [Bioorg. Med. Chem. Lett. 29 (2019) 2575-2580]. Fradera X; Methot JL; Achab A; Christopher M; Altman MD; Zhou H; McGowan MA; Kattar SD; Wilson K; Garcia Y; Augustin MA; Lesburg CA; Shah S; Goldenblatt P; Katz JD Bioorg Med Chem Lett; 2020 Aug; 30(16):127363. PubMed ID: 32591133 [No Abstract] [Full Text] [Related]
7. Corrigendum to "Metabolism-based structure optimization: Discovery of a potent and orally available tyrosine kinase ALK inhibitor bearing the tetracyclic benzo[b]carbazolone core" [Bioorg. Med. Chem. Lett. 26 (2016) 5399-5402]. Han M; Wang C; Ji Y; Song Z; Xing L; Su Y; Wang X; Zhang A; Ai J; Geng M Bioorg Med Chem Lett; 2020 Feb; 30(4):126931. PubMed ID: 31902709 [No Abstract] [Full Text] [Related]
8. Corrigendum to "A novel intestinal-restricted FXR agonist" [Bioorg Med Chem Lett 27 (2017) 3386-3390]. Wang H; Zhao Z; Zhou J; Guo Y; Wang G; Hao H; Xu X Bioorg Med Chem Lett; 2017 Dec; 27(23):5353. PubMed ID: 29110987 [No Abstract] [Full Text] [Related]
9. Corrigendum to "Discovery and lead optimisation of a potent, selective and orally bioavailable RARβ agonist for the potential treatment of nerve injury" [Bioorg. Med. Chem. Lett. 29(8) (2019) 995-1000]. Goncalves MB; Clarke E; Jarvis CI; Kalindjian SB; Pitcher T; Grist J; Hobbs C; Carlstedt T; Jack J; Brown JT; Mills M; Mumford P; Borthwick AD; Corcoran JPT Bioorg Med Chem Lett; 2019 Aug; 29(16):2440-2441. PubMed ID: 31208764 [No Abstract] [Full Text] [Related]
10. Corrigendum to "Dimeric sesquiterpene and thiophenes from the roots of Echinops latifolius" [Bioorg. Med. Chem. Lett. 26 (2016) 5995-5998]. Jin Q; Lee JW; Jang H; Choi JE; Kim HS; Lee D; Hong JT; Lee MK; Hwang BY Bioorg Med Chem Lett; 2017 Mar; 27(6):1490. PubMed ID: 28202326 [No Abstract] [Full Text] [Related]
11. Corrigendum to "Discovery of benzofuran propanoic acid GPR120 agonists: From uHTS hit to mechanism-based pharmacodynamic effects" [Bioorg. Med. Chem. Lett. 26 (2016) 5724-5728]. Lombardo M; Bender K; London C; Plotkin MA; Kirkland M; Mane J; Pachanski M; Geissler W; Cummings J; Habulihaz B; Akiyama TE; Di Salvo J; Madeira M; Pols J; Powles MA; Finley MF; Johnson E; Roussel T; Uebele VN; Crespo A; Leung D; Alleyne C; Trusca D; Lei Y; Howard AD; Ujjainwalla F; Tata JR; Sinz CJ Bioorg Med Chem Lett; 2017 Mar; 27(5):1333. PubMed ID: 28169160 [No Abstract] [Full Text] [Related]
12. Corrigendum to "Biochemical, cellular and structural characterization of novel and selective ERK3 inhibitors" [Bioorg. Med. Chem. Lett. 30 (2020) 127551]. Grädler U; Busch M; Leuthner B; Raba M; Burgdorf L; Lehmann M; Linde N; Esdar C Bioorg Med Chem Lett; 2021 Oct; 49():128262. PubMed ID: 34352662 [No Abstract] [Full Text] [Related]
13. Corrigendum to "Metal-assisted synthesis of unsymmetrical magnolol and honokiol analogs and their biological assessment as GABA Rycek L; Puthenkalam R; Schnürch M; Ernst M; Mihovilovic MD Bioorg Med Chem Lett; 2015 Apr; 25(8):1811. PubMed ID: 28718421 [No Abstract] [Full Text] [Related]
14. Corrigendum to "Novel GlyT1 inhibitor chemotypes by scaffold hopping. Part 2: Development of a [3.3.0]-based series and other piperidine bioisosteres" [Bioorg. Med. Chem. Lett. 24 (2014) 1062-1066]. Sheffler DJ; Nedelcovych MT; Williams R; Turner SC; Duerk BB; Robbins MR; Jadhav SB; Niswender CM; Jones CK; Conn PJ; Nathan Daniels R; Lindsley CW Bioorg Med Chem Lett; 2017 May; 27(9):2079. PubMed ID: 28347668 [No Abstract] [Full Text] [Related]
15. Corrigendum to "Preventive effect of a novel diosgenin derivative on arterial and venous thrombosis in vivo" [Bioorg. Med. Chem. Lett. 26 (2016) 3364-3369]. Zheng H; Wei Z; Xin G; Ji C; Wen L; Xia Q; Niu H; Huang W Bioorg Med Chem Lett; 2016 Sep; 26(17):4386. PubMed ID: 27474444 [No Abstract] [Full Text] [Related]
16. Corrigendum to "Synthesis and biological evaluation of novel benzamide derivatives as potent smoothened antagonists" [Bioorg. Med. Chem. Lett. 24/5 (2014) 1426-1431]. Wu TM; Wang DC; Xiang P; Zhang JN; Sang YX; Lin HJ; Chen J; Xie G; Song H; Zhao YL; Xie YM Bioorg Med Chem Lett; 2016 Sep; 26(18):4558. PubMed ID: 27542309 [No Abstract] [Full Text] [Related]
17. Corrigendum to 'Easy and rapid preparation of benzoylhydrazides and their diazene derivatives as inhibitors of 15-lipoxygenase' [Bioorg. Med. Chem. Lett. 27 (2017) 1649-1653]. Tirapegui C; Acevedo-Fuentes W; Dahech P; Torrent C; Barrias P; Rojas-Poblete M; Mascayano C Bioorg Med Chem Lett; 2017 Sep; 27(17):4218. PubMed ID: 28780158 [No Abstract] [Full Text] [Related]
18. Corrigendum to "Synthesis and carbonic anhydrase inhibitory properties of novel chalcone substituted benzenesulfonamides" [Bioorg. Med. Chem. Lett. 26 (2016) 5867-5870]. Arslan T; Türkoğlu EA; Şentürk M; Supuran CT Bioorg Med Chem Lett; 2017 Aug; 27(16):3944. PubMed ID: 28705642 [No Abstract] [Full Text] [Related]
19. Corrigendum to "Strategies for the development of highly selective cytochrome P450 inhibitors: Several CYP targets in current research" [Bioorg. Med. Chem. Lett. 29 (2019) 2016-2024]. Zhao L; Sun N; Tian L; Zhao S; Sun B; Sun Y; Zhao D Bioorg Med Chem Lett; 2021 Aug; 45():128140. PubMed ID: 34052643 [No Abstract] [Full Text] [Related]
20. Corrigendum to "Development of hydrocortisone succinic acid/and 5-fluorouracil/chitosan microcapsules for oral and topical drug deliveries" [Bioorg. Med. Chem. Lett. 22 (2012) 3213-3218]. Lam PL; Lee KK; Wong RS; Cheng GYM; Cheng SY; Yuen MC; Lam KH; Gambari R; Kok SH; Chui CH Bioorg Med Chem Lett; 2014 Sep; 24(18):4607. PubMed ID: 28923534 [No Abstract] [Full Text] [Related] [Next] [New Search]